Conversations in Drug Development
Science:Life Sciences
In this episode, host Harriet Edwards is joined by Dr Katherine Bowen and Shalini Gupta to explore the transformative changes in the European Union's clinical trial landscape. The focus is on the transition from the Clinical Trials Directive (CTD) to the Clinical Trials Regulation (CTR) and its significant impact on the regulatory environment.
Join us for an insightful discussion on how the CTR is shaping the future of clinical research in Europe and the positive impact it aims to have on patients.
More Episodes
How to Effectively De-Risk your IND Process
2025-02-11
485
2025-02-11
485
Navigating the Future of EU Health Technology Assessments
2024-10-16
316
2024-10-16
316
A Guide to Marketing Authorization Applications in Europe
2024-09-24
332
2024-09-24
332
Demystifying Regulatory Designations in Drug Development
2024-07-10
339
2024-07-10
339
Exploring Genome Editing Technologies in Drug Development
2024-06-19
313
2024-06-19
313
The Most Essential Tips for Biotechs Seeking Investment
2024-06-03
322
2024-06-03
322
The Use of ATMPs in Oncology Clinical Trials
2024-05-21
292
2024-05-21
292
The Regulatory Challenges of Rare Disease Drug Development
2024-02-28
460
2024-02-28
460
Recent Trends in Oncology Drug Development
2023-10-04
633
2023-10-04
633
Get this podcast on your
phone, FREE
